These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16434131)

  • 1. Recombinant Salmonella vaccines for biodefence.
    Atkins HS; Morton M; Griffin KF; Stokes MG; Nataro JP; Titball RW
    Vaccine; 2006 Apr; 24(15):2710-7. PubMed ID: 16434131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella-based plague vaccines for bioterrorism.
    Calhoun LN; Kwon YM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):92-7. PubMed ID: 16604240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant-attenuated Salmonella vaccines modified to reduce virulence.
    Constable L
    Expert Rev Vaccines; 2011 Aug; 10(8):1117. PubMed ID: 21961199
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational design of Salmonella recombinant vaccines.
    Cheminay C; Hensel M
    Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live bacterial delivery systems for development of mucosal vaccines.
    Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M
    Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral vectors for use in the development of biodefense vaccines.
    Lee JS; Hadjipanayis AG; Parker MD
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmonella as a vaccine delivery vehicle.
    Roland KL; Brenneman KE
    Expert Rev Vaccines; 2013 Sep; 12(9):1033-45. PubMed ID: 24053397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous protection in pigs induced by a plasmid-cured and crp gene-deleted Salmonella choleraesuis live vaccine.
    Chu CY; Wang SY; Chen ZW; Chien MS; Huang JP; Chen JJ; Hong LS; Shiau AL; Tsai JL; Wu CL
    Vaccine; 2007 Oct; 25(41):7031-40. PubMed ID: 17825957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficulties associated with the development and licensing of vaccines for protection against bio-warfare and bio-terrorism.
    Langford MJ; Myers RC
    Dev Biol (Basel); 2002; 110():107-12. PubMed ID: 12477313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK
    Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.
    Fensterle J; Bergmann B; Yone CL; Hotz C; Meyer SR; Spreng S; Goebel W; Rapp UR; Gentschev I
    Cancer Gene Ther; 2008 Feb; 15(2):85-93. PubMed ID: 18084243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Salmonella vaccination technology and its application to human bacterial pathogens.
    Zhang S; Walters N; Cao L; Robison A; Yang X
    Curr Pharm Biotechnol; 2013; 14(2):209-19. PubMed ID: 23360265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of recombinant Salmonella strains for supplying the macro-organism with biologically active molecules].
    Bondarenko VM; Beliavskaia VA; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (3):70-9. PubMed ID: 12141046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explorative probes and biomarkers, chronic Salmonella infections and future vaccines.
    Michán C; Ramos JL; Daniels C
    Microb Biotechnol; 2012 Jan; 5(1):1-4. PubMed ID: 22103324
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Clark-Curtiss JE; Curtiss R
    J Immunol; 2018 Jan; 200(1):39-48. PubMed ID: 29255088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system.
    Salam MA; Katz J; Zhang P; Hajishengallis G; Michalek SM
    Vaccine; 2006 Jun; 24(23):5003-15. PubMed ID: 16621196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protective immunity conferred by a DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine in calves challenged with Salmonella serovar Newport.
    Mohler VL; Heithoff DM; Mahan MJ; Walker KH; Hornitzky MA; Shum LW; Makin KJ; House JK
    Vaccine; 2008 Mar; 26(14):1751-8. PubMed ID: 18329764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive models and correlates of protection for testing biodefence vaccines.
    Williamson ED; Duchars MG; Kohberger R
    Expert Rev Vaccines; 2010 May; 9(5):527-37. PubMed ID: 20450327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.